Chugai Pharmaceutical Co., Ltd.
Símbolo: CHGCF
PNK
32.43
USDPrecio de mercado actual
25.3981
Ratio PER
-0.0058
Ratio PEG
53.36B
Capitalización MRK
- 0.00%
Rendimiento DIV
Chugai Pharmaceutical Co., Ltd. (CHGCF) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2787296 | 738982 | 503107 | 471970 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 1169402 | 280308 | 280938 | 204217 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 1175428 | 320348 | 514283 | 356009 | |||||||||||||||||||||
balance-sheet.row.inventory | 1094030 | 273480 | 292206 | 208838 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 161328 | 33616 | 26941 | 26844 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 5218082 | 1366426 | 1336537 | 1063661 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1670723 | 420701 | 386651 | 352107 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 10984 | 1254 | -279101 | -201824 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 263786 | 64474 | 65244 | 56287 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 235887 | 59832 | 335286 | 246489 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 2261468 | 566121 | 533221 | 475033 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 7479550 | 1932547 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.account-payables | 353134 | 54234 | 209835 | 152266 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 6975 | 6975 | 6434 | 6550 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 140811 | 40798 | 98543 | 86312 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 6480 | 6480 | -430 | -490 | |||||||||||||||||||||
Deferred Revenue Non Current | 378 | 378 | 430 | 490 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 20615 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 729647 | 226977 | 207382 | 168520 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 73820 | 18749 | 21641 | 23255 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 29351 | 6480 | 7675 | 9490 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1163607 | 306966 | 445371 | 350677 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 292808 | 73202 | 73202 | 73202 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 5765677 | 1488738 | 1293352 | 1054050 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -19740 | -5714 | -10972 | -7457 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 277198 | 69354 | 68805 | 68222 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 7479550 | 1932546 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 7479550 | - | - | - | |||||||||||||||||||||
Total Investments | 1170656 | 281562 | 1837 | 2393 | |||||||||||||||||||||
balance-sheet.row.total-debt | 36326 | 13455 | 14109 | 16040 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1581568 | -445219 | -208060 | -251713 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 398330 | 325472 | 575875 | 470367 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2700 | 31740 | 31434 | 30868 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | -66477 | -76520 | -179886 | -138487 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 384301 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 17093 | 19346 | -7285 | 1042 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -569376 | -545983 | -519002 | -372264 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 574541 | 546962 | 442919 | 325028 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | -17977 | 15161 | 8613 | 133 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -35455 | -38772 | -145994 | -118927 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -5842 | -7863 | 0 | -9079 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 171 | 217 | 241 | 322 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -7 | -5 | -5 | -8 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -131188 | -131594 | -138220 | -98644 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -1954 | -5 | -7657 | 1 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -138841 | -139250 | -145641 | -107408 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5171 | 3202 | 1939 | 2128 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 215177 | 236505 | -45584 | 55420 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1617894 | 458674 | 222169 | 267753 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1402717 | 222169 | 267753 | 212333 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 384301 | 411326 | 244112 | 279626 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 324698 | 337068 | 172873 | 206760 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1036075 | 1111367 | 1259946 | 999759 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 334928 | 418358 | 476251 | 338147 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 701147 | 693009 | 783695 | 661612 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 173268 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | -6604 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 265960 | 277344 | 250386 | 239715 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 600888 | 695702 | 726637 | 577862 | |||||||||||||||||||||
income-statement-row.row.interest-income | 1404 | 1482 | 182 | 166 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4183 | 31740 | -2082 | -2464 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 439372 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 435189 | 415665 | 533309 | 421897 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 444048 | 443821 | 531166 | 419385 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 117676 | 118349 | 156737 | 116390 | |||||||||||||||||||||
income-statement-row.row.net-income | 326373 | 325472 | 374429 | 302995 |
Preguntas frecuentes
Cuánto es Chugai Pharmaceutical Co., Ltd. (CHGCF) activos totales?
Chugai Pharmaceutical Co., Ltd. (CHGCF) los activos totales son 1932547000000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 510761000000.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.677.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 197.344.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.315.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.420.
¿Qué es Chugai Pharmaceutical Co., Ltd. (CHGCF) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 325472000000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 13455000000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 277344000000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 462863000000.000.